サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1671179

老人用医薬品の世界市場、規模、シェア、動向、産業分析レポート：治療薬別、病態別、流通チャネル別、地域別 - 市場予測（2025年～2034年）

Global Geriatric Medicines Market Size, Share, Trends, Industry Analysis Report: By Therapeutics, Condition, Distribution Channel, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 117 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
老人用医薬品の世界市場、規模、シェア、動向、産業分析レポート：治療薬別、病態別、流通チャネル別、地域別 - 市場予測（2025年～2034年）
出版日: 2025年02月01日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の老人用医薬品の市場規模は2034年までに3,405億米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

老人用医薬品は、老年薬物療法としても知られ、高齢者向けに特別に設計された医薬品治療の開発、使用、管理に焦点を当てた医学の専門分野を指します。この分野は、心血管疾患、糖尿病、関節炎、神経疾患、呼吸器疾患などの慢性疾患を含む、加齢に伴う独特の生理学的変化や健康課題に対処するものです。

老人用医薬品市場は、世界の高齢化人口の増加と、心血管疾患、糖尿病、関節炎、神経変性疾患などの慢性疾患や加齢関連疾患の有病率の上昇によって牽引されています。同市場における主なビジネスチャンスとしては、個別化医療の発展、年齢に特化した薬剤製剤の開発、新興国市場におけるヘルスケアインフラの拡大などが挙げられます。

遠隔医療やウェアラブル端末などのデジタルヘルス技術の統合といった動向は、高齢者の治療へのアクセスを向上させ、治療のアドヒアランスを改善しています。また、予防医療やバイオシミラーへの投資も増加しており、費用対効果の高いソリューションが提供されています。全体として、高齢者向け医薬品市場は、革新的で利用しやすい治療に対する需要が世界的に高まり続けていることから、安定した成長が見込まれています。

老人用医薬品市場レポートハイライト

高齢者の糖尿病有病率の高さから、抗糖尿病薬分野が市場を独占しており、GLP-1受容体作動薬などの革新的治療薬に対する需要の高まりが成長を牽引しています。

高齢者の心臓関連疾患の負担が大きいことから、循環器系疾患が最大の市場シェアを占める一方、アルツハイマー病やパーキンソン病の有病率の増加により神経系疾患が最も急成長しています。

一方、オンライン薬局は、在宅配送の利便性とデジタルヘルスプラットフォームの採用増加により、急成長を記録しています。

北米は高度なヘルスケアインフラと高齢者人口の増加に支えられ、市場を独占しています。一方、アジア太平洋は、高齢者人口の拡大と医療アクセスの改善に後押しされ、最も急成長している地域です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の老人用医薬品市場の洞察

  • 市場スナップショット
  • 老人用医薬品市場力学
    • 促進要因と機会
      • 年齢に応じた医薬品の需要増加
      • 高齢患者向け個別化医療の進歩
    • 抑制要因と課題
      • 高齢者ヘルスケアの高額な費用
  • PESTEL分析
  • 老人用医薬品市場の応用動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の老人用医薬品市場：治療薬別

  • 主な調査結果
  • イントロダクション
  • 鎮痛剤
  • スタチン
  • 抗糖尿病薬
  • プロトンポンプ阻害剤（PPI）
  • 抗凝固剤
  • 抗精神病薬
  • その他

第6章 世界の老人用医薬品市場：病態別

  • 主な調査結果
  • イントロダクション
  • 心血管疾患
  • 神経疾患
  • がん
  • 糖尿病と代謝障害
  • 呼吸器疾患
  • その他

第7章 世界の老人用医薬品市場：流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 世界の老人用医薬品市場：地域別

  • 主な調査結果
  • イントロダクション
    • 老年用医薬品市場の評価、地域、2020年～2034年
  • 北米
    • 北米：治療薬別、2020年～2034年
    • 北米：病態別、2020年～2034年
    • 北米：流通チャネル別、2020年～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：治療薬別、2020年～2034年
    • 欧州：病態別、2020年～2034年
    • 欧州：流通チャネル別、2020年～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：治療薬別、2020年～2034年
    • アジア太平洋：病態別、2020年～2034年
    • アジア太平洋：流通チャネル別、2020年～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：治療薬別、2020年～2034年
    • 中東・アフリカ：病態別、2020年～2034年
    • 中東・アフリカ：流通チャネル別、2020年～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：治療薬別、2020年～2034年
    • ラテンアメリカ：病態別、2020年～2034年
    • ラテンアメリカ：流通チャネル別、2020年～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Pfizer Inc.
  • Novartis International AG
  • Sanofi
  • GlaxoSmithKline
  • Merck & Co.
  • AbbVie
  • AstraZeneca
  • Johnson & Johnson
  • Eli Lilly and Company
  • Roche
図表

List of Tables:

  • Table 1 Global Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 2 Global Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 3 Global Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 4 North America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 5 North America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 6 North America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 7 U.S.: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 8 U.S.: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 9 U.S.: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 10 Canada: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 11 Canada: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 12 Canada: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 13 Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 14 Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 15 Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 16 UK: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 17 UK: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 18 UK: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 19 France: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 20 France: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 21 France: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 22 Germany: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 23 Germany: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 24 Germany: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Italy: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 26 Italy: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 27 Italy: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 28 Spain: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 29 Spain: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 30 Spain: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 34 Russia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 35 Russia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 36 Russia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 43 China: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 44 China: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 45 China: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 46 India: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 47 India: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 48 India: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 52 Japan: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 53 Japan: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 54 Japan: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 58 South Korea: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 59 South Korea: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 60 South Korea: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 Australia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 62 Australia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 63 Australia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 73 UAE: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 74 UAE: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 75 UAE: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 76 Israel: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 77 Israel: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 78 Israel: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 79 South Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 80 South Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 81 South Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 86 Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 87 Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 88 Mexico: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 89 Mexico: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 90 Mexico: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 91 Brazil: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 92 Brazil: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 93 Brazil: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 94 Argentina: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 95 Argentina: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 96 Argentina: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Geriatric Medicines Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapeutics
  • Figure 7. Global Geriatric Medicines Market, by Therapeutics, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Condition
  • Figure 9. Global Geriatric Medicines Market, by Condition, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Geriatric Medicines Market, by Distribution Channel, 2024 & 2034 (USD Billion)
目次
Product Code: PM1338

The global geriatric medicines market size is expected to reach USD 340.50 billion by 2034, according to a new study by Polaris Market Research. The report "Geriatric Medicines Market Size, Share, Trends, Industry Analysis Report: By Therapeutics (Analgesics, Statins, Antidiabetic, Proton Pump Inhibitors (PPIs), Anticoagulant, Antipsychotic, and Others), Condition, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Geriatric medicines, also known as geriatric pharmacotherapy, refer to a specialized branch of medicine focused on the development, use, and management of pharmaceutical treatments designed specifically for elderly individuals. This area addresses the unique physiological changes and health challenges associated with aging, including chronic conditions such as cardiovascular diseases, diabetes, arthritis, neurological disorders, and respiratory diseases.

The geriatric medicines market is driven by the growing global aging population and the rising prevalence of chronic and age-related diseases such as cardiovascular conditions, diabetes, arthritis, and neurodegenerative disorders. Key opportunities in the market include advancements in personalized medicine, the development of age-specific drug formulations, and the expansion of healthcare infrastructure in emerging markets.

Trends such as the integration of digital health technologies, including telemedicine and wearable devices, are enhancing access to care and improving treatment adherence among older adults. The market is also seeing increasing investments in preventive healthcare and biosimilars to provide cost-effective solutions. Overall, the geriatric medicines market is poised for steady growth as demand for innovative and accessible treatments continues to rise globally.

Geriatric Medicines Market Report Highlights

The antidiabetic segment dominates the market due to the high prevalence of diabetes among the elderly, with rising demand for innovative treatments such as GLP-1 receptor agonists driving growth.

Cardiovascular diseases account for the largest geriatric medicines market share, driven by the significant burden of heart-related conditions in older adults, while neurological disorders are the fastest-growing segment due to the increasing prevalence of Alzheimer's and Parkinson's diseases.

Hospital pharmacies lead the market as they are primary points of care for elderly patients with chronic diseases, whereas online pharmacies are registering the fastest growth due to the convenience of home delivery and the rising adoption of digital health platforms.

North America dominates the market, supported by advanced healthcare infrastructure and a growing elderly population, while Asia Pacific is the fastest-growing region, fueled by its expanding geriatric demographic and improving healthcare access.

Polaris Market Research has segmented the geriatric medicines market report based on therapeutics, condition, distribution channel, and region:

By Therapeutics Outlook (Revenue-USD Billion, 2020 - 2034)

  • Analgesics
  • Statins
  • Antidiabetic
  • Proton Pump Inhibitors (PPIs)
  • Anticoagulant
  • Antipsychotic
  • Others

By Condition Outlook (Revenue-USD Billion, 2020 - 2034)

  • Cardiovascular Diseases
  • Neurological Disorders
  • Cancer
  • Diabetes & Metabolic Disorders
  • Respiratory Diseases
  • Others

By Distribution Channel Outlook (Revenue-USD Billion, 2020 - 2034)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Regional Outlook (Revenue-USD Billion, 2020 - 2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Geriatric Medicines Market Insights

  • 4.1. Geriatric Medicines Market - Market Snapshot
  • 4.2. Geriatric Medicines Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Demand for Age-Specific Medications
      • 4.2.1.2. Advancements in Personalized Medicine for Elderly Patients
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Geriatric Healthcare
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Geriatric Medicines Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Geriatric Medicines Market, by Therapeutics

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  • 5.3. Analgesics
    • 5.3.1. Global Geriatric Medicines Market, by Analgesics, by Region, 2020-2034 (USD Billion)
  • 5.4. Statins
    • 5.4.1. Global Geriatric Medicines Market, by Statins, by Region, 2020-2034 (USD Billion)
  • 5.5. Antidiabetic
    • 5.5.1. Global Geriatric Medicines Market, by Antidiabetic, by Region, 2020-2034 (USD Billion)
  • 5.6. Proton Pump Inhibitors (PPIs)
    • 5.6.1. Global Geriatric Medicines Market, by Proton Pump Inhibitors (PPIs), by Region, 2020-2034 (USD Billion)
  • 5.7. Anticoagulant
    • 5.7.1. Global Geriatric Medicines Market, by Anticoagulant, by Region, 2020-2034 (USD Billion)
  • 5.8. Antipsychotic
    • 5.8.1. Global Geriatric Medicines Market, by Antipsychotic, by Region, 2020-2034 (USD Billion)
  • 5.9. Others
    • 5.9.1. Global Geriatric Medicines Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Geriatric Medicines Market, by Condition

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  • 6.3. Cardiovascular Diseases
    • 6.3.1. Global Geriatric Medicines Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
  • 6.4. Neurological Disorders
    • 6.4.1. Global Geriatric Medicines Market, by Neurological Disorders, by Region, 2020-2034 (USD Billion)
  • 6.5. Cancer
    • 6.5.1. Global Geriatric Medicines Market, by Cancer, by Region, 2020-2034 (USD Billion)
  • 6.6. Diabetes & Metabolic Disorders
    • 6.6.1. Global Geriatric Medicines Market, by Diabetes & Metabolic Disorders, by Region, 2020-2034 (USD Billion)
  • 6.7. Respiratory Diseases
    • 6.7.1. Global Geriatric Medicines Market, by Respiratory Diseases, by Region, 2020-2034 (USD Billion)
  • 6.8. Others
    • 6.8.1. Global Geriatric Medicines Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Geriatric Medicines Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Geriatric Medicines Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Global Geriatric Medicines Market, by Retail Pharmacy, by Region, 2020-2034 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Global Geriatric Medicines Market, by Online Pharmacy, by Region, 2020-2034 (USD Billion)

8. Global Geriatric Medicines Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Geriatric Medicines Market Assessment, b y Geography, 2020-2034 (USD Billion)
  • 8.3. Geriatric Medicines Market - North America
    • 8.3.1. North America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.3.2. North America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.3.3. North America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.4. Geriatric Medicines Market - US
      • 8.3.4.1. US : Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.3.4.2. US : Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.3.4.3. U S: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.5. Geriatric Medicines Market - Canada
      • 8.3.5.1. Canada: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.4. Geriatric Medicines Market - Europe
    • 8.4.1. Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.4. Geriatric Medicines Market - UK
      • 8.4.4.1. UK: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.5. Geriatric Medicines Market - France
      • 8.4.5.1. France: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.6. Geriatric Medicines Market - Germany
      • 8.4.6.1. Germany: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.7. Geriatric Medicines Market - Italy
      • 8.4.7.1. Italy: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.8. Geriatric Medicines Market - Spain
      • 8.4.8.1. Spain: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.9. Geriatric Medicines Market - Netherlands
      • 8.4.9.1. Netherlands: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.10. Geriatric Medicines Market - Russia
      • 8.4.10.1. Russia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.11. Geriatric Medicines Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.5. Geriatric Medicines Market - Asia Pacific
    • 8.5.1. Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.4. Geriatric Medicines Market - China
      • 8.5.4.1. China: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.5. Geriatric Medicines Market - India
      • 8.5.5.1. India: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.6. Geriatric Medicines Market - Malaysia
      • 8.5.6.1. Malaysia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.7. Geriatric Medicines Market - Japan
      • 8.5.7.1. Japan: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.8. Geriatric Medicines Market - Indonesia
      • 8.5.8.1. Indonesia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.9. Geriatric Medicines Market - South Korea
      • 8.5.9.1. South Korea: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.10. Geriatric Medicines Market - Australia
      • 8.5.10.1. Australia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.11. Geriatric Medicines Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.6. Geriatric Medicines Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.4. Geriatric Medicines Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.5. Geriatric Medicines Market - UAE
      • 8.6.5.1. UAE: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.6. Geriatric Medicines Market - Israel
      • 8.6.6.1. Israel: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.7. Geriatric Medicines Market - South Africa
      • 8.6.7.1. South Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.8. Geriatric Medicines Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.7. Geriatric Medicines Market - Latin America
    • 8.7.1. Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.4. Geriatric Medicines Market - Mexico
      • 8.7.4.1. Mexico: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.5. Geriatric Medicines Market - Brazil
      • 8.7.5.1. Brazil: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.6. Geriatric Medicines Market - Argentina
      • 8.7.6.1. Argentina: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.7. Geriatric Medicines Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Pfizer Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Novartis International AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Sanofi
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. GlaxoSmithKline
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Merck & Co.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. AbbVie
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. AstraZeneca
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Eli Lilly and Company
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Roche
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development